← Back to directory

Andrew Ustianowski

Researcher Next ID · RN-028389

Researcher · Medicine

North Manchester General Hospital

Manchester, Slovakia

Not currently recruitingFunding unknown
Works count
218
Citation count
22,121
H-index
49
i10-index
118

Research interests

Medicine
COVID-19 Clinical Research Studies
SARS-CoV-2 and COVID-19 Research
Hepatitis C virus research
Long-Term Effects of COVID-19
HIV/AIDS Research and Interventions

Publications

  • Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

    The Lancet · 2022 · 10.1016/s0140-6736(22)02597-1

  • Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

    New England Journal of Medicine · 2022 · 10.1056/nejmoa2116620

  • Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

    The Lancet · 2021 · 10.1016/s0140-6736(21)02717-3

  • Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey

    Life · 2021 · 10.3390/life11030249

  • Alterations in T and B cell function persist in convalescent COVID-19 patients

    Med · 2021 · 10.1016/j.medj.2021.03.013

  • Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

    New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2028700

  • Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

    medRxiv · 2020 · 10.1101/2020.08.27.20183442

  • Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19

    Science Immunology · 2020 · 10.1126/sciimmunol.abd6197

  • Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial

    medRxiv · 2020 · 10.1101/2020.07.15.20151852

  • Dexamethasone in Hospitalized Patients with Covid-19.

    DiRROS repository (University of Maribor) · 2020 · https://doi.org/10.17863/cam.57006

  • Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

    medRxiv · 2020 · https://doi.org/10.1101/2020.06.22.20137273

  • Viral Hepatitis

    Infectious Disease Clinics of North America · 2019 · 10.1016/j.idc.2019.08.004

  • British HIV Association guidelines for the treatment of HIV ‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

    HIV Medicine · 2013 · https://doi.org/10.1111/hiv.12119

  • Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register

    Annals of the Rheumatic Diseases · 2012 · 10.1136/annrheumdis-2011-201108

  • British HIV Association guidelines for the treatment of HIV ‐1‐positive adults with antiretroviral therapy 2012

    HIV Medicine · 2012 · https://doi.org/10.1111/j.1468-1293.2012.01029.x

  • B ritish HIV A ssociation guidelines for the routine investigation and monitoring of adult HIV ‐1‐infected individuals 2011

    HIV Medicine · 2011 · https://doi.org/10.1111/j.1468-1293.2011.00971.x

  • Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

    Annals of the Rheumatic Diseases · 2011 · https://doi.org/10.1136/ard.2011.152769

  • Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

    Lara D. Veeken · 2010 · 10.1093/rheumatology/keq242

  • Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

    Annals of the Rheumatic Diseases · 2009 · https://doi.org/10.1136/ard.2009.118935

  • Fever in returned travellers presenting in the United Kingdom: Recommendations for investigation and initial management

    Journal of Infection · 2009 · 10.1016/j.jinf.2009.05.005

  • Interactions between HIV infection and leprosy: a paradox

    The Lancet Infectious Diseases · 2006 · 10.1016/s1473-3099(06)70493-5

  • Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London

    Journal of Infection · 2004 · 10.1016/j.jinf.2004.07.006

  • Diagnostics for the developing world

    Nature Reviews Microbiology · 2004 · https://doi.org/10.1038/nrmicro841

  • A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death.

    PubMed · 1999

Current projects

    No projects listed.